Global Alpha Capital Management Ltd. Myriad Genetics Inc Transaction History

Global Alpha Capital Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$9.78 - $29.53 $4.73 Million - $14.3 Million	-484,100 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$20.93 - $35.1 $4.74 Million - $7.95 Million	226,400 Added 87.85%	484,100 $13.2 Million
Q3 2019 Nov 13, 2019	SELL	$22.08 - $47.08 $249,503 - $532,004	-11,300 Reduced 4.2%	257,700 $7.38 Million
Q2 2019 Aug 07, 2019	BUY	$22.67 - $35.0 $6.1 Million - $9.42 Million	269,000 New	269,000 $7.47 Million

244

91.2M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Global Alpha Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Global Alpha Capital Management Ltd. with notifications on news.